Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12253/1498
Title: | Prevalence of Polypharmacy of Older People in a Large Brazilian Urban Center and its Associated Factors |
Authors: | Vitorino, Luciano M. Mendes, Jorge L. Santos, Gerson S. Oliveira, Cláudia José, Helena Sousa, L.M.M. |
Keywords: | Polypharmacy Aged Frail elderly |
Issue Date: | May-2023 |
Publisher: | International Journal of Environmental Research and Public Health |
Citation: | Vitorino, L.; Mendes, J.; Santos, G.; Oliveira, C.; José, H.; Sousa, L.M.M. (2023). Prevalence of Polypharmacy of Older People in a Large Brazilian Urban Center and its Associated Factors. International Journal of Envirionmental Research and Public Health, 20, 5730. https://doi.org/10.3390/ ijerph20095730. |
Abstract: | Background: With the aging population comes greater risks associated with polypharmacy, a significant public health problem. Objective: This study aimed to identify the prevalence of polypharmacy and its associated factors through Comprehensive Geriatric Assessment (CGA) among older adults treated in primary health care (PHC) in a large Brazilian urban center. Methods: We conducted a cross-sectional study with a random sampling of 400 older adults using primary health care. Polypharmacy was defined as the cumulative use of five or more daily medications. An assessment of a sociodemographic and health survey, fear of falling, and physical disabilities affecting activities of daily living and instrumental activities of daily living was conducted. Results: The mean age was 75.23 (SD: 8.53) years. The prevalence of polypharmacy and hyperpolypharmacy was 37% (n = 148) and 1% (n = 4), respectively. The adjusted logistic regression showed that participants with chronic non-communicable diseases (CNCDs) (OR = 9.24; p = 0.003), diabetes (OR = 1.93; p = 0.003), and obesity (OR = 2.15; p = 0.005) were associated with a greater propensity to use polypharmacy. Conclusion: Our results show that older adults with CNCDs, diabetes, and obesity were more likely to use polypharmacy. The results reinforce the importance of using CGA in clinical practice in PHC. |
URI: | http://hdl.handle.net/20.500.12253/1498 |
Appears in Collections: | E CS/ENF - Artigos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ijerph-20-05730-v2.pdf | 377.02 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.